title: [Diagnosis of ileal carcinoid with contrast enhanced ultrasonic diagnosis].
authors.affiliation: Medizinische Klinik, AMEOS-Klinikum St. Salvator Halberstadt, Halberstadt. rickes@medkl.salvator-kh.de
authors.forename: Steffen
authors.initials: S
authors.lastname: Rickes
authors.forename: Christine
authors.initials: C
authors.lastname: Uhle
authors.forename: Holger
authors.initials: H
authors.lastname: Neye
authors.forename: Daniel
authors.initials: D
authors.lastname: Ensberg
authors.forename: Peter
authors.initials: P
authors.lastname: Rauh
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D002276:Carcinoid Tumor / Q000098:blood supply / Q000000981:diagnostic imaging* / Q000473:pathology / Q000556:secondary* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D053379:Chromogranin A / Q000097:blood; D003131:Combined Modality Therapy; D003287:Contrast Media; D017809:Fatal Outcome; D005260:Female; D005483:Flushing / Q000209:etiology*; D006801:Humans; D007078:Ileal Neoplasms / Q000098:blood supply / Q000000981:diagnostic imaging* / Q000473:pathology / Q000601:surgery; D007082:Ileum / Q000473:pathology / Q000601:surgery; D008113:Liver Neoplasms / Q000098:blood supply / Q000000981:diagnostic imaging* / Q000556:secondary*; D008875:Middle Aged; D009325:Nausea / Q000209:etiology*; D015282:Octreotide / Q000627:therapeutic use; D010743:Phospholipids; D012039:Regional Blood Flow / Q000502:physiology; D013459:Sulfur Hexafluoride; D014463:Ultrasonography; D014839:Vomiting / Q000209:etiology*
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D053379:Chromogranin A; D003287:Contrast Media; D010743:Phospholipids; C420843:contrast agent BR1; D015282:Octreotide; D013459:Sulfur Hexafluoride